Medical devices, healthcare technology and the business of care
510(k) clearance · K263461

Tendon Anchor

Smith & Nephew, Inc. · Decision date Oct 27, 2026

MEDTECHLEDGER EXPLANATIONK263461

What did the FDA decide?

FDA recorded a substantial equivalence decision dated October 27, 2026 for K263461, a Tendon Anchor submitted by Smith & Nephew, Inc. of Andover, Massachusetts. The submission was received September 28, 2026, and the public record lists the medical specialty as General and Plastic Surgery under product code GDW. A substantial equivalence determination is a 510(k) clearance, not premarket approval of a new device.

The FDA document states the intended use as fixation of the REGENETEN Bioinductive Implant to soft tissues, which places the anchor as a fixation component used with that implant rather than as a standalone therapeutic device. The record does not describe the anchor's materials, dimensions, or any design change relative to a predicate, and no predicate device number appears in the available excerpts. Clinical performance data and labeling details are likewise not included in the source material reviewed.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General, Plastic Surgery
Decision date
Oct 27, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K263461
Regulatory pathway
510(k) premarket notification
Product code
GDW
Decision code
SESE
Decision date
Oct 27, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Staple, Implantable.

Product code
GDW
FDA device class
2

FDA decision timeline

  1. K263461 received

    Application receipt date recorded by FDA.

  2. K263461 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code GDW

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Smith & Nephew, Inc.

Headquarters
Not reported
Brand website
smith-nephew.com
FDA applicant address
Andover, MA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records